TY - JOUR
T1 - Long-term efficacy and complications of a multicentre randomised controlled trial comparing retropubic and transobturator mid-urethral slings
T2 - a prospective observational study
AU - for the MONARC™ study group
AU - Offiah, I.
AU - Freeman, R.
AU - Offiah, I.
AU - Freeman, R.
AU - Waterfield, M.
AU - Lochhead, K.
AU - Hillard, T.
AU - Madhu, C.
AU - Sultan, A.
AU - James, M.
AU - Foley, S.
AU - Buckley, S.
AU - Speaksman, M.
AU - Reid, F.
AU - Abrams, P.
N1 - Publisher Copyright:
© 2021 John Wiley & Sons Ltd.
PY - 2021/12
Y1 - 2021/12
N2 - Objective: There are concerns regarding the risks of mid-urethral slings (MUS) for stress urinary incontinence (SUI), particularly because of the lack of long-term data. We compare patient-reported outcomes of a multicentre randomised controlled trial of retropubic (TVT, GYNECARE™) versus transobturator (TOT, MONARC™) tape surgery at 12 years. Design and setting: A multicentre study was performed in 11 tertiary referral centres. Population: A cohort of 180 participants from the original trial, the majority of whom had mixed urinary incontinence. Methods: Postal questionnaire survey of patient-reported outcome measures using the International Consultation on Incontinence Questionnaire, Patient Global Impression of Improvement questionnaire (PGI-I) and a numeric rating scale pain questionnaire. Main outcome measures: Comparison of the efficacy and complications between the TVT and TOT procedures in the long term. Results: A total of 110/180 responses were received: 55 for TVT and 55 for TOT. The mean follow-up was 12.8 ± 0.29 years (SD). TVT was significantly superior to TOT: 41.8% TVT with no SUI, versus 21.8% TOT (P = 0.04). Urgency urinary incontinence (UUI) was the most bothersome urinary symptom: 14.5% of respondents reported UUI after TVT and TOT. This was an improvement from the baseline levels: 61.8% TVT and 76.4% TOT. Seventeen patients (9 TVT and 8 TOT) out of 121 reported moderate or severe pain with severe pain in 3 with TVT and 2 with TOT. Overall, 80% TVT and 77% TOT participants reported their symptoms as improved on the PGI-I. Conclusions: TVT is superior to TOT for SUI cure. Efficacy is reduced by 12 years. There is low incidence of severe vaginal or groin pain. Careful patient counselling on long-term outcomes is required. The Retropubic tape appears to be an effective treatment for the majority of women with SUI. Tweetable abstract: Retropubic tape has superior efficacy to transobturator tape. Complications are comparable with low rates.
AB - Objective: There are concerns regarding the risks of mid-urethral slings (MUS) for stress urinary incontinence (SUI), particularly because of the lack of long-term data. We compare patient-reported outcomes of a multicentre randomised controlled trial of retropubic (TVT, GYNECARE™) versus transobturator (TOT, MONARC™) tape surgery at 12 years. Design and setting: A multicentre study was performed in 11 tertiary referral centres. Population: A cohort of 180 participants from the original trial, the majority of whom had mixed urinary incontinence. Methods: Postal questionnaire survey of patient-reported outcome measures using the International Consultation on Incontinence Questionnaire, Patient Global Impression of Improvement questionnaire (PGI-I) and a numeric rating scale pain questionnaire. Main outcome measures: Comparison of the efficacy and complications between the TVT and TOT procedures in the long term. Results: A total of 110/180 responses were received: 55 for TVT and 55 for TOT. The mean follow-up was 12.8 ± 0.29 years (SD). TVT was significantly superior to TOT: 41.8% TVT with no SUI, versus 21.8% TOT (P = 0.04). Urgency urinary incontinence (UUI) was the most bothersome urinary symptom: 14.5% of respondents reported UUI after TVT and TOT. This was an improvement from the baseline levels: 61.8% TVT and 76.4% TOT. Seventeen patients (9 TVT and 8 TOT) out of 121 reported moderate or severe pain with severe pain in 3 with TVT and 2 with TOT. Overall, 80% TVT and 77% TOT participants reported their symptoms as improved on the PGI-I. Conclusions: TVT is superior to TOT for SUI cure. Efficacy is reduced by 12 years. There is low incidence of severe vaginal or groin pain. Careful patient counselling on long-term outcomes is required. The Retropubic tape appears to be an effective treatment for the majority of women with SUI. Tweetable abstract: Retropubic tape has superior efficacy to transobturator tape. Complications are comparable with low rates.
KW - Complications
KW - long-term patient-reported outcomes
KW - retropubic mid-urethral sling
KW - stress urinary incontinence
KW - transobturator mid-urethral sling
UR - https://www.scopus.com/pages/publications/85116562255
U2 - 10.1111/1471-0528.16899
DO - 10.1111/1471-0528.16899
M3 - Article
C2 - 34478604
AN - SCOPUS:85116562255
SN - 1470-0328
VL - 128
SP - 2191
EP - 2199
JO - BJOG: An International Journal of Obstetrics and Gynaecology
JF - BJOG: An International Journal of Obstetrics and Gynaecology
IS - 13
ER -